Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Zidovudine-Experienced Patients

Intervention.—Patients received either 200 mg of zidovudine every 8 hours, 150 mg of lamivudine every 12 hours plus zidovudine, or 300 mg of lamivudine every 12 hours plus zidovudine for 24 weeks

Schlomo Staszewski

2011

Scholarcy highlights

  • Intervention.—Patients received either 200 mg of zidovudine every 8 hours, 150 mg of lamivudine every 12 hours plus zidovudine, or 300 mg of lamivudine every 12 hours plus zidovudine for 24 weeks
  • Main Outcome Measures.—Effcacy was measured by evaluating immunological and viral load changes, and safety was assessed by evaluating clinical manifestations and laboratory indexes of toxic effects
  • FDA Approval and Regulation of Pharmaceuticals, 1983-2018 Global Burden of Cancer, 1990-2017 Global Burden of Skin Diseases, 1990-2017 Global Firearm Mortality, 1990-2016 Health Care Spending in the US and Other High-Income Countries Life Expectancy and Mortality Rates in the United States, 1959-2017 Medical Marketing in the United States, 1997-2016 Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter President Obama on US Health Care Reform The State of US Health, 1990-2016 US Burden of Cardiovascular Disease, 1990-2016 US Burden of Neurological Disease, 1990-2017 Waste in the US Health Care System: Estimated Costs and Potential for Savings

Need more features? Save interactive summary cards to your Scholarcy Library.